Mechanisms of diastolic dysfunction in heart failure

被引:94
作者
Borlaug, Barry A.
Kass, David A.
机构
[1] Johns Hopkins Med Inst, Dept Med, Div Cardiol, Baltimore, MD 21205 USA
[2] Mayo Clin Coll Med, Dept Med, Div Cardiol, Rochester, MN 55905 USA
关键词
D O I
10.1016/j.tcm.2006.05.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Abnormalities of diastole are common to most forms of congestive heart failure (HF). Diastolic function is broadly defined as the ability of the heart to fill adequately and at normal pressure to charge the ventricular pump for each subsequent contraction. It is determined by both active and passive processes occurring at the level of the myocyte, extracellular matrix, and left ventricular chamber. Forces extrinsic to the myocardium-such as the influence of right heart filling, pericardial and extracardiac constraints, and cardiac preload and afterload also contribute. Nearly half of patients with HF have apparently preserved systolic function, and this has focused attention on diastolic dysfunction as a dominant contributor to symptoms, sparking interest for understanding and treating diastolic abnonnalities. This review focuses on the mechanisms determining normal and pathologic cardiac relaxation and distensibility and highlights how these abnormalities may be therapeutically targeted to improve diastolic function in human HF.
引用
收藏
页码:273 / 279
页数:7
相关论文
共 58 条
  • [1] Matrix metalloproteinases/tissue inhibitors of metalloproteinases - Relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease
    Ahmed, SH
    Clark, LL
    Pennington, WR
    Webb, CS
    Bonnema, DD
    Leonardi, AH
    McClure, CD
    Spinale, FG
    Zile, MR
    [J]. CIRCULATION, 2006, 113 (17) : 2089 - 2096
  • [2] An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness
    Asif, M
    Egan, J
    Vasan, S
    Jyothirmayi, GN
    Masurekar, MR
    Lopez, S
    Williams, C
    Torres, RL
    Wagle, D
    Ulrich, P
    Cerami, A
    Brines, M
    Regan, TJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (06) : 2809 - 2813
  • [3] Cross-linking influences the impact of quantitative changes in myocardial collagen on cardiac stiffness and remodelling in hypertension in rats
    Badenhorst, D
    Maseko, M
    Tsotetsi, OJ
    Naidoo, A
    Brooksbank, R
    Norton, GR
    Woodiwiss, AJ
    [J]. CARDIOVASCULAR RESEARCH, 2003, 57 (03) : 632 - 641
  • [4] Left ventricular systolic performance, function, and contractility in patients with diastolic heart failure
    Baicu, CF
    Zile, MR
    Aurigemma, GP
    Gaasch, WH
    [J]. CIRCULATION, 2005, 111 (18) : 2306 - 2312
  • [5] Borlaug BA, 2005, CIRCULATION, V112, pU663
  • [6] Sildenafil inhibits β-adrenergic-stimulated cardiac contractility in humans
    Borlaug, BA
    Melenovsky, V
    Marhin, T
    Fitzgerald, P
    Kass, DA
    [J]. CIRCULATION, 2005, 112 (17) : 2642 - 2649
  • [7] The Irbesartan in Heart Failure with Preserved Systolic Function (I-PRESERVE) trial: Rationale and design
    Carson, P
    Massie, BM
    McKelvie, R
    McMurray, J
    Komajda, M
    Zile, M
    Ptaszynska, A
    Frangin, G
    [J]. JOURNAL OF CARDIAC FAILURE, 2005, 11 (08) : 576 - 585
  • [8] CONTRIBUTION OF EXTERNAL FORCES TO LEFT-VENTRICULAR DIASTOLIC PRESSURE - IMPLICATIONS FOR THE CLINICAL USE OF THE STARLING LAW
    DAUTERMAN, K
    PAK, PH
    MAUGHAN, WL
    NUSSBACHER, A
    ARIE, S
    LIU, CP
    KASS, DA
    [J]. ANNALS OF INTERNAL MEDICINE, 1995, 122 (10) : 737 - 742
  • [9] Targeting phospholamban by gene transfer in human heart failure
    del Monte, F
    Harding, SE
    Dec, GW
    Gwathmey, JK
    Hajjar, RJ
    [J]. CIRCULATION, 2002, 105 (08) : 904 - 907
  • [10] Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients
    Díez, J
    Querejeta, R
    López, B
    González, A
    Larman, M
    Ubago, JLM
    [J]. CIRCULATION, 2002, 105 (21) : 2512 - 2517